Trinh  Phung net worth and biography

Trinh Phung Biography and Net Worth

Trinh serves Shockwave Medical as the Vice President of Finance, following a year as Corporate Controller. She joined the team following a 5-year tenure as Controller from Ariosa Diagnostics, which was acquired by Roche in 2015.

 

Previously, Trinh held various roles of increasing responsibility at Intersil Corporation, Quicklogic Corporation, Artisan Components, Inc. and Ernst and Young LLP. She has over 18 years of experience in public accounting and including hardware/software, life sciences, and start-up companies.

 

Trinh earned her BS from Santa Clara University and is an inactive Certified Public Accountant.

What is Trinh Phung's net worth?

The estimated net worth of Trinh Phung is at least $10.21 million as of March 6th, 2024. Ms. Phung owns 31,024 shares of Shockwave Medical stock worth more than $10,206,896 as of April 21st. This net worth estimate does not reflect any other assets that Ms. Phung may own. Learn More about Trinh Phung's net worth.

How old is Trinh Phung?

Ms. Phung is currently 46 years old. There are 5 older executives and no younger executives at Shockwave Medical. The oldest executive at Shockwave Medical is Mr. John M. Adams, Co-Founder and Technical Advisor, who is 77 years old. Learn More on Trinh Phung's age.

How do I contact Trinh Phung?

The corporate mailing address for Ms. Phung and other Shockwave Medical executives is 5403 Betsy Ross Drive, Santa Clara CA, 95054. Shockwave Medical can also be reached via phone at (877) 775-4846 and via email at [email protected]. Learn More on Trinh Phung's contact information.

Has Trinh Phung been buying or selling shares of Shockwave Medical?

Trinh Phung has not been actively trading shares of Shockwave Medical over the course of the past ninety days. Most recently, Trinh Phung sold 21 shares of the business's stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $253.14, for a transaction totalling $5,315.94. Following the completion of the sale, the vice president now directly owns 31,024 shares of the company's stock, valued at $7,853,415.36. Learn More on Trinh Phung's trading history.

Who are Shockwave Medical's active insiders?

Shockwave Medical's insider roster includes Colin Cahill (Director), Laura Francis (Director), Douglas Godshall (CEO), Antoine Papiernik (Director), Trinh Phung (VP), Dan Puckett (CFO), Maria Sainz (Director), Frank Watkins (Director), and Isaac Zacharias (Insider). Learn More on Shockwave Medical's active insiders.

Are insiders buying or selling shares of Shockwave Medical?

In the last year, insiders at the sold shares 44 times. They sold a total of 217,491 shares worth more than $51,068,089.53. The most recent insider tranaction occured on March, 26th when Director Laura Francis sold 1,500 shares worth more than $450,000.00. Insiders at Shockwave Medical own 3.4% of the company. Learn More about insider trades at Shockwave Medical.

Information on this page was last updated on 3/26/2024.

Trinh Phung Insider Trading History at Shockwave Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2024Sell21$253.14$5,315.9431,024View SEC Filing Icon  
2/22/2024Sell599$259.24$155,284.7631,031View SEC Filing Icon  
2/6/2024Sell1,287$232.18$298,815.6632,933View SEC Filing Icon  
12/7/2023Sell203$171.63$34,840.8929,037View SEC Filing Icon  
6/23/2023Sell62$295.91$18,346.4221,101View SEC Filing Icon  
4/26/2023Sell1,828$300.00$548,400.0021,341View SEC Filing Icon  
4/19/2023Sell251$264.67$66,432.1723,169View SEC Filing Icon  
2/22/2023Sell640$188.09$120,377.6023,879View SEC Filing Icon  
2/3/2023Sell941$187.23$176,183.4325,740View SEC Filing Icon  
8/26/2022Sell3,500$310.76$1,087,660.0025,063View SEC Filing Icon  
6/23/2022Sell62$179.35$11,119.7028,563View SEC Filing Icon  
4/18/2022Sell565$206.28$116,548.2028,688View SEC Filing Icon  
4/12/2022Sell3,176$215.61$684,777.3629,695View SEC Filing Icon  
See Full Table

Trinh Phung Buying and Selling Activity at Shockwave Medical

This chart shows Trinh Phung's buying and selling at Shockwave Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Shockwave Medical Company Overview

Shockwave Medical logo
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $329.00
Low: $327.39
High: $329.80

50 Day Range

MA: $285.92
Low: $230.90
High: $329.64

2 Week Range

Now: $329.00
Low: $157.00
High: $331.58

Volume

1,302,719 shs

Average Volume

2,092,707 shs

Market Capitalization

$12.30 billion

P/E Ratio

85.01

Dividend Yield

N/A

Beta

0.92